| Agilent–Akoya Biosciences: IHC diagnostics, 202301– collab developm + marketing solutions integrating Dako Omnis instrument + PhenoImager HT system |
|
| Biometra–Analytik Jena: investment, 200905 acquisition of Biometra by Analytik Jena |
2009-05-11 |
| Cambridge Research & Instrumentation–Caliper: investment, 2010 acquisition of CRI by Caliper Life Sciences |
2010-01-01 |
| Pharmaprogress–Kymos: investment, 2016 merger of Pharmaprogress Srl + Kymos SL |
2016-01-01 |
| Rockefeller Univ–Lumicks: microscope, 2016 supply of C-Trap system as first installation in the US in lab of Prof Shixin Liu |
2016-01-01 |
| Elitech–PAI Partners: investment, 201705– acquisition of Elitech Group by PAI Partners from Ergon Capital Partners |
2017-05-11 |
| Intabio–SEVERAL: investment, 201709 seed financing round $2m led by Jenny Rooke + incl Vertical Ventures + Morgan Noble + several individuals |
2017-09-14 |
| Charles River–SAMDI Tech: drug discovery, 2018– collab using SAMDI MS technology for label-free high-throughput screening |
2018-01-01 |
| Exum Instruments–Elemental Scientific: investment, 2018 TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exum Instruments–Elemental Scientific: Massbox, 2018– TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exum Instruments–Free Radical Ventures: investment, 2018 early investment by Free Radical Ventures |
2018-01-01 |
| Exum Instruments–TOFwerk: investment, 2018 TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Exum Instruments–TOFwerk: Massbox, 2018– TOFwerk + ESI join as equity partners to design + produce first instrument |
2018-01-01 |
| Platinum Informatics–Scotland (govt): grant, 201805c feasability grant from Scottish Enterprise for proteomic s/w product development |
2018-05-01 |
| QT Holdings–Bio-Techne: investment, 201806 acquisition $20.5m of Quad Technologies by Bio-Techne |
2018-07-06 |
| Proteomedix–Altos Venture: investment, 201808 financing round totalling CHF5.2m incl exising + lead investor Altos Venture |
2018-08-27 |
| Proteomedix–SEVERAL: investment, 201808 financing round CHF5.2m from exising investors led by Altos Venture + incl ZKB |
2018-08-27 |
| Proteomedix–Zürcher Kantonalbank: investment, 201808 financing round totalling CHF5.2m incl exising + co-investor ZKB |
2018-08-27 |
| Exum Instruments–SEVERAL: investment, 2019 seed financing round |
2019-01-01 |
| Shimadzu–Plasmion: ionisation technology, 2019– collab exchange of tech info + lending of Shimadzu porducts + development of SICRIT applications |
2019-01-01 |
| Numares–Mayo Clinic: NMR spectroscopy, 201902– collab developm metabolomics-based NMR clinical tests with Mayo Clinic Labs |
2019-02-05 |
| B-MoGen Biotechnologies–Bio-Techne: investment, 201904 acquisition $17.4m of B-Mogen by Bio-Techne |
2019-06-04 |
| Ellab–EQT: investment, 201908–201909 acquisition €na majority share by EQT Mid Market Europe Fund from IK VIII Fund |
2019-08-07 |
| Cobra Biologics–Cognate BioServices: investment, 201911–202001 acquisition of Cobra by Cognate BioServices |
2019-11-04 |
| Mobilion–SEVERAL: investment, 201911 financing round Series A $15.4m led by Agilent |
2019-11-12 |
| Promega–Merck (DE): CRISPR technology, 201912– license to CRISPR IP io from Merck to Promega to develop CRISPR-edited cell lines |
2019-12-19 |
| BugLab–Aber Instruments: investment, 202009–202102 acquisition €na of assets of BugLab LLC incl IP + trademarks |
2020-01-01 |
| Mérieux–Accellix: quality control diagnostics, 2020– collab serving shared key customers of bioMérieux + Accellix in CAGT segment |
2020-01-01 |
| Sartorius–Nvidia: AI-based drug discovery + manufacturing, 2020– collab integration of Nvidia technology in Sartorius instruments + for simulations |
2020-01-01 |
| Tecan–Labforward: laboratory software, 2020– collab integration of Tecan detection devices with Labfolder LIMS |
2020-01-01 |
| TrueMass–OTHER: investment, 2020– significant seed funding from business angels |
2020-01-01 |
| Bruker–Adeptrix: MS-based immunoassays, 202101– collab developm BAMS assays on Bruker MALDI-MS systems |
2020-01-06 |
| Andrew Alliance–Waters: investment, 202001 acquisition $80m by existent investor Waters |
2020-01-13 |
| Danaher–Sophia Genetics: genomic technologies, 202001– collab ww expansion IDT NGS enrichment products with Sophia Genetics DDM for clinical research |
2020-01-15 |
| Piramal–Clarivate: investment, 202001–202002 acquisition Decision Resources by Clarivate Analytics from Piral Enterprises $900m cash + $50m shares |
2020-01-17 |
| Cognate BioServices–Essex Woodlands: investment, 202001 financing round Series B incl existing + lead investor EW Healthcare Partners |
2020-01-21 |
| Cognate BioServices–Medivate Partners: investment, 202001 financing round Series B incl co-investor Medivate Partners |
2020-01-21 |
| Cognate BioServices–SEVERAL: investment, 202001 financing round Series B led by EW Healthcare Partners + incl Medivate Partners |
2020-01-21 |
| Fluidigm–Georgetown Univ: mass cytometry, 202002– collab establishment of joint CoE for Imaging Mass Cytometry at Georgetown Lombardi CCC |
2020-02-10 |
| Georgetown Univ–Fluidigm: mass cytometry, 202002– supply Hyperion Imaging System for new CoE for Imaging Mass Cytometry at GLCCC |
2020-02-10 |
| LabCorp–Fluidigm: mass cytometry, 202002– supply Covance selects CyTOF technology incl Maxpar Direct Immune Profiling Assay for drug dev services |
2020-02-10 |
| NanoPin Technologies–Thermo Fisher: mass spectrometry, 202002– collab developm LC-MS-based workflows for blood-based infectious disease diagnostics |
2020-02-13 |
| OMass–SEVERAL: investment, 202002 financing round Series A extension £27.5m bringing total Series A to £41.5m |
2020-02-17 |
| BIA Separations–Univ Zagreb: purification technology, 202002– commercial license + collab developm of virus + viral vector immunoaffinity purification |
2020-02-19 |
| InstruNor–Fluidigm: investment, 202002 acquisition $7.2m with $5.2m in cash + $2m in stock |
2020-02-26 |
| Danaher–Sherlock Biosciences: molecular diagnostics, 202002– collab developm of Cepheid GeneXpert tests using CRISPR-based SHERLOCK technology |
2020-02-28 |
| Agilent–Visiopharm: image analysis software, 202003– collab co-marketing of Visiopharm’s AI-driven solutions for digital pathology |
2020-03-02 |
| Sterling Pharma Solutions–Thermo Fisher: LC system, 202003 supply early customer for Vanquish Core HPLC System |
2020-03-02 |
| Danaher–UDG Healthcare: public relations, 202003 service existent for Cepheid by Canale Communciations |
2020-03-21 |
| Gustave Roussy–Biognosys: MS-based proteomics, 202004– collab using proteomic profiling in attempt to repurpose tocilizumab for Covid-19 |
2020-04-28 |
| Endress+Hauser–Roboscreen: investment, 202006 management buy-out of Roboscreen GmbH from Analytik Jena AG Group |
2020-06-01 |
| Univ Bochum–Max Planck: antibiotics research, 202006– collab establishment CESAR Center for Antibiotics Research at Univ Bochum with LDC |
2020-06-18 |
| Univ Bochum–North Rhine-Westphalia (govt): grant, 202006– grant €4m from NRW + EFRO for establishment CESAR Center for Antibiotics Research with LDC |
2020-06-18 |
| Resolution Spectra Systems–Merck (DE): investment, 202007 acquisition €na of Resolution Spectra Systems by Merck |
2020-07-01 |
| Waters–Heidrick & Struggles: recruitment services, 202007 supply service placement of Udit Batra as CEO of Waters |
2020-07-01 |
| Boehringer–Biognosys: HRM mass spectrometry, 202007– collab using HRM/DIA MS + Spectronaut s/w for drug discovery |
2020-07-23 |
| DNA Script–SEVERAL: investment, 202007 financing round Series B extension $50m led by Casdin Capital |
2020-07-29 |
| Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab |
2020-08-07 |
| Mobilion–Agilent: investment, 202008 financing round Series B totalling $35m incl existing + co-investor Agilent Technologies |
2020-08-17 |
| Mobilion–aMoon: investment, 202008 financing round Series B totalling $35m incl new + lead investor aMoon |
2020-08-17 |
| Mobilion–Cultivation Capital: investment, 202008 financing round Series B totalling $35m incl existing + co-investor Cultivation Capital |
2020-08-17 |
| Mobilion–Hostplus: investment, 202008 financing round Series B totalling $35m incl existing + co-investor Hostplus |
2020-08-17 |
| Mobilion–IP Group: investment, 202008 financing round Series B totalling $35m incl existing + co-investor IP Group |
2020-08-17 |
| Mobilion–SEVERAL: investment, 202008 financing round Series B $35m led by aMoon + incl Agilent + IP Group + Hostplus + Cultivation Capital |
2020-08-17 |
| Univ Guelph–Bruker: NMR spectrometer, 202008 supply existent of 400 MHz NMR spectrometer + Fourier 80 benchtop NRM system |
2020-08-24 |
| Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich |
2020-09-01 |
| Canopy Biosciences–Bruker: investment, 202009 acquisition $24.4m of Canopy Biosciences LLC by Bruker Corp |
2020-09-11 |
| Prolytic–Kymos: investment, 202009 strategic merger of Polytic GmbH + Kymos SL |
2020-09-28 |
| Integrated Proteomics Applications–Bruker: investment, 202009 acquisition €na of assets by Bruker |
2020-09-30 |
| BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED |
2020-10-02 |
| Eurofins–Waters: mass spectrometer, 202011 supply existent Radian ASAP System beta customer Eurofins Forenscis Teddington |
2020-11-02 |
| Horizon Discovery–PerkinElmer: investment, 202011– cash tender offer £296m ($383m) representing total enterprise value of £284m ($368m) |
2020-11-02 |
| m2p-labs–Danaher: investment, 202011 acquisition of m2p-biolabs by Beckman Coulter Life Sciences |
2020-11-12 |
| Univ Pennsylvania–Agilent: grant, 202011– Thought Leader Award to Carl H June + M Milone at School of Medicine for cancer cell therapy |
2020-11-17 |
| Emphysys–Paramit: investment, 202011 acquisition of Emphysis Inc by Paramit Corp |
2020-11-24 |
| SomaLogic–SEVERAL: investment, 202011 financing round Series A initial closing $121m led by Casdin Capital |
2020-11-25 |
| Newomics–SEVERAL: investment, 202012 financing round Series B $7.9m led by MSA Capital |
2020-12-01 |
| Slack Technologies–Salesforce: investment, 202012– acquisition $27.7b in cash + shares of Slack by Salesforce ANNOUNCED |
2020-12-01 |
| Kyungpook National Univ–Waters: mass spectrometer, 202012 supply first Select Series Cyclic IMS system in South Korea to S Kim |
2020-12-08 |
| Waters–Kyungpook National Univ: mass spectrometry, 202012– collab research expansion with S Kim using Cyclic IMS system for crude oil analysis |
2020-12-08 |
| Mediaire–High-Tech Gründerfonds: investment, 202012 seed financing round totalling €2m incl investor HTGF |
2020-12-16 |
| Mediaire–LIFTT (IT): investment, 202012 seed financing round totalling €2m incl investor LIFTT SpA |
2020-12-16 |
| Mediaire–PrimeCrowd: investment, 202012 seed financing round totalling €2m incl investor PrimeCrowd |
2020-12-16 |
| Mediaire–SEVERAL: investment, 202012 seed financing round approx €2m incl HTGF + PrimeCrowd + LIFTT |
2020-12-16 |
| 908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m net $136.6m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market |
2020-12-18 |
| SomaLogic–Amgen: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Amgen |
2020-12-22 |
| SomaLogic–Boston Millennia Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Boston Millenia Partners |
2020-12-22 |
| SomaLogic–Intermountain Ventures: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Intermountain Ventures |
2020-12-22 |
| SomaLogic–Janus Henderson: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Janus Henderson Investors |
2020-12-22 |
| SomaLogic–Logos Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Logos Capital |
2020-12-22 |
| SomaLogic–Millenium Management: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Millennium Management |
2020-12-22 |
| SomaLogic–NEC: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl NEC Solution Innovators Ltd |
2020-12-22 |
| SomaLogic–Novartis: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Novartis |
2020-12-22 |
| SomaLogic–Redmile Group: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Redmile Group |
2020-12-22 |
| SomaLogic–Revelation Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Revelation Partners |
2020-12-22 |
| SomaLogic–SEVERAL: investment, 202012 financing round Series A 2nd closing additional $81m bringing total Series A to $204m or $214m |
2020-12-22 |
| SomaLogic–Ziff Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Ziff Capital Healthcare Ventures |
2020-12-22 |
| Distributed Bio–Charles River: investment, 202012 acquisition $83m upfront cash + $21m milestones |
2020-12-31 |
| Phitonex–Thermo Fisher: investment, 202012 acquisition fo Phitonex by Thermo Fisher Scientific |
2020-12-31 |
| Adeptrix–Bruker: investment, 202101 financing round Series A incl new + minority investor Bruker Corp |
2021-01-06 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spec-capital-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
